• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国睑缘炎患者的就医历程与疾病负担

The patient journey and burden of disease in blepharitis in the United States.

作者信息

Periman Laura M, Whitley Walter O, Maiti Sathi, Mun James, Ho Anh N, Oak Bhagyashree, Athavale Amod, Yeu Elizabeth

机构信息

Periman Eye Institute, Seattle, WA, USA.

Virginia Eye Consultants, Norfolk, VA, USA.

出版信息

J Med Econ. 2025 Dec;28(1):734-742. doi: 10.1080/13696998.2025.2500224. Epub 2025 May 21.

DOI:10.1080/13696998.2025.2500224
PMID:40314599
Abstract

AIM

blepharitis (DB) is a chronic eyelid disease caused by an infestation of mites. The objective of this chart audit study was to characterize the patient journey and burden of illness associated with DB from an eye-care provider's perspective.

METHODS

Retrospective medical data for patients with a confirmed diagnosis of DB were anonymously collected ophthalmologists and optometrists in the US (collectively eye-care providers [ECPs]), in June-July 2022. Each eligible ECP completed a questionnaire and provided chart abstractions of 1-5 medical charts of patients with DB in an electronic case report form.

RESULTS

All ECPs ( = 61) were ophthalmologists or optometrists who worked primarily in office-based private practices (97%). Data from 192 medical charts of patients with an ECP-confirmed diagnosis of DB were abstracted and their demographics included 54% males and 71% Caucasians. The mean time (±SD) since diagnosis was 11 (±9.0) years. Over 40% of patients were not examined for DB at initial presentation, and the average time from initial presentation to a definitive diagnosis for DB was 6.5 months. After DB diagnosis and across the period of observation until the time of the study, patients had a mean (±SD) of 3.2 (±2.8) follow-up visits due to DB and continued to use multiple off-label prescription and over-the-counter therapies for symptom management.

LIMITATION

Medical records may be incomplete or inconsistently reported and subject to recall bias.

CONCLUSIONS

The patient journey is lengthy with multiple challenges, including delay in DB diagnosis and recurring DB symptoms, underlining an urgent need for action to improve diagnosis and treatment of DB.

摘要

目的

睑缘炎(DB)是一种由螨虫感染引起的慢性眼睑疾病。本图表审核研究的目的是从眼科护理提供者的角度描述与DB相关的患者病程和疾病负担。

方法

2022年6月至7月,在美国,眼科医生和验光师(统称为眼科护理提供者[ECP])匿名收集了确诊为DB的患者的回顾性医疗数据。每位符合条件的ECP填写一份问卷,并以电子病例报告表的形式提供1至5例DB患者的病历摘要。

结果

所有ECP(n = 61)均为主要在门诊私人诊所工作的眼科医生或验光师(97%)。提取了192例经ECP确诊为DB的患者的病历数据,其人口统计学特征包括54%为男性,71%为白种人。自诊断以来的平均时间(±标准差)为11(±9.0)年。超过40%的患者在初次就诊时未接受DB检查,从初次就诊到DB确诊的平均时间为6.5个月。在DB诊断后以及直至研究时的观察期内,患者因DB平均(±标准差)进行了3.2(±2.8)次随访,并继续使用多种非标签处方和非处方疗法来管理症状。

局限性

医疗记录可能不完整或报告不一致,且存在回忆偏倚。

结论

患者病程漫长且面临多重挑战,包括DB诊断延迟和DB症状反复出现,这凸显了迫切需要采取行动改善DB的诊断和治疗。

相似文献

1
The patient journey and burden of disease in blepharitis in the United States.美国睑缘炎患者的就医历程与疾病负担
J Med Econ. 2025 Dec;28(1):734-742. doi: 10.1080/13696998.2025.2500224. Epub 2025 May 21.
2
Tea tree oil for Demodex blepharitis.茶树油治疗睑缘蠕形螨睑缘炎。
Cochrane Database Syst Rev. 2020 Jun 20;6(6):CD013333. doi: 10.1002/14651858.CD013333.pub2.
3
Multidisciplinary perspectives in blepharitis: A new view of treatment from clinical, payer, and patient perspectives.睑缘炎的多学科视角:从临床、支付方和患者角度看治疗的新观点。
J Manag Care Spec Pharm. 2024 Oct;30(10-a Suppl):S1-S8. doi: 10.18553/jmcp.2024.30.10-a.s1.
4
Patient-Reported Burden of Illness and Unmet Needs in blepharitis.患者报告的睑缘炎疾病负担和未满足的需求
Patient Prefer Adherence. 2025 Mar 18;19:647-658. doi: 10.2147/PPA.S501764. eCollection 2025.
5
Efficacy of Terpinen-4-ol Combined With Eyelid Deep Cleaning for the Treatment of Demodex Blepharitis: A Randomized, Open-Label Trial.萜品烯-4-醇联合睑缘深层清洁治疗蠕形螨性睑缘炎的疗效:一项随机、开放标签试验。
Transl Vis Sci Technol. 2024 Nov 4;13(11):22. doi: 10.1167/tvst.13.11.22.
6
In vivo confocal microscopy as a novel and reliable tool for the diagnosis of Demodex eyelid infestation.体内共聚焦显微镜检查作为诊断睑螨感染的一种新型可靠工具。
Br J Ophthalmol. 2015 Mar;99(3):336-41. doi: 10.1136/bjophthalmol-2014-305671. Epub 2014 Sep 24.
7
Efficacy and Safety of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Meta-Analysis of Randomized Controlled Trials.Lotilaner 眼科溶液 0.25% 治疗蠕形螨性睑缘炎的疗效和安全性:一项随机对照试验的荟萃分析。
Cont Lens Anterior Eye. 2024 Jun;47(3):102148. doi: 10.1016/j.clae.2024.102148. Epub 2024 Mar 21.
8
Permethrin Cream for the Treatment of Demodex Blepharitis.林丹乳膏治疗蠕形螨性睑缘炎。
Cornea. 2019 Dec;38(12):1513-1518. doi: 10.1097/ICO.0000000000002013.
9
Efficacy of Topical Ivermectin 1% in the Treatment of Demodex Blepharitis.局部使用 1%伊维菌素治疗蠕形螨睑缘炎的疗效。
Cornea. 2022 Apr 1;41(4):427-434. doi: 10.1097/ICO.0000000000002802.
10
Demodex folliculorum and Demodex brevis as a cause of chronic marginal blepharitis.毛囊蠕形螨和皮脂蠕形螨作为慢性睑缘炎的病因
Ann Acad Med Stetin. 2007;53(1):63-7; discussion 67.